Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PLX - Protalix BioTherapeutics targets phase 2 launch for PRX-115 in H2 2025

PLX - Protalix BioTherapeutics targets phase 2 launch for PRX-115 in H2 2025

May, 09 2025 04:13 PM Protalix BioTherapeutics Inc.

2025-05-09 16:13:20 ET

More on Protalix BioTherapeutics

Protalix BioTherapeutics, Inc. (PLX) Q1 2025 Earnings Call Transcript
Protalix BioTherapeutics Is A Strong Buy With Increasing Revenues And A Promising Pipeline
Protalix BioTherapeutics, Inc. (PLX) Q4 2024 Earnings Call Transcript
Protalix BioTherapeutics Q1 Earnings Preview
Protalix plans Phase 2 for PRX-115 in H2 2025, projects higher royalty revenues by 2030

For further details see:

Protalix BioTherapeutics targets phase 2 launch for PRX-115 in H2 2025

Stock Information

Company Name:	Protalix BioTherapeutics Inc.
Stock Symbol:	PLX
Market:	NYSE
Website:	protalix.com

PLX PLX Quote PLX Short PLX News PLX Articles PLX Message Board

Get PLX Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.